Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hiroko Okabayashi"'
Autor:
Hiroko Okabayashi, Tomohisa Baba, Hideya Kitamura, Eri Hagiwara, Toshihiro Misumi, Satoshi Ikeda, Takashi Ogura, Ryo Okuda, Takuma Katano, Shigeru Komatsu, Akimasa Sekine, Hideaki Yamakawa
Publikováno v:
Respiratory Investigation. 59:414-420
Pirfenidone is an anti-fibrotic agent approved for idiopathic pulmonary fibrosis (IPF), and long-term treatment data and the effect of continuation after disease progression have been reported. The efficacy and safety of pirfenidone in fibrosing inte
Autor:
Tomohisa Baba, Kota Murohashi, Atsuhito Nakazawa, Shigeru Komatsu, Takafumi Yamaya, Hiroko Okabayashi, Hideya Kitamura, Takeshi Kaneko, Katsuyuki Higa, Tsuneyuki Oda, Takashi Ogura, Ryota Otoshi, Ryo Okuda, Eri Hagiwara, Akimasa Sekine, Takashi Niwa, Yozo Sato, Ryota Shintani, Tae Iwasawa, Takaaki Kitayama, Satoshi Ikeda
Publikováno v:
Respiratory Investigation
Although the use of corticosteroids is not recommended in the World Health Organization statement for the treatment of coronavirus disease 2019 (COVID-19), steroid therapy may be indicated for critical cases in specific situations. Here, we report th
Autor:
Yasumiko Jodai, Yusuke Tomita, Toyohisa Iriki, Kazuhiko Fujii, Shinji Iyama, Hiroko Okabayashi, Kimitaka Akaike, Koichi Saruwatari, Takayuki Jodai, Shohei Hamada, Hidenori Ichiyasu, Ryo Sato, Shinya Sakata, Sho Saeki
Publikováno v:
Anticancer Research. 38:6543-6550
BACKGROUND/AIM The impact of interstitial lung disease (ILD) on the clinical outcome of patients with small-cell lung cancer (SCLC) is not fully understood. The aim of this study was to investigate the impact of ILD on treatment and survival outcomes
Autor:
Shinichiro Okamoto, Keisuke Kojima, Takayuki Jodai, Hidenori Ichiyasu, Kimitaka Akaike, Yasumiko Sakamoto, Hirotsugu Kohrogi, Hiroko Okabayashi, Hideharu Ideguchi, Susumu Hirosako, Shohei Hamada, Chieko Yoshida, Sayuri Hirooka
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-10 (2017)
Background Rapidly progressive interstitial pneumonias (RPIPs) associated with clinically amyopathic dermatomyositis (CADM) are highly resistant to therapy and have a poor prognosis. Multimodal therapies, including direct hemoperfusion using a polymy
Autor:
Aiko Masunaga, Hideharu Ideguchi, Shohei Hamada, Yasumiko Sakamoto, Hirotsugu Kohrogi, Yuko Horio, Yohei Migiyama, Susumu Hirosako, Hidenori Ichiyasu, Takayuki Jodai, Chieko Yoshida, Hiroko Okabayashi, Shinichiro Okamoto
Publikováno v:
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 11 (2017)
Therapeutic Advances in Respiratory Disease, Vol 11 (2017)
Background: Direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) therapy has been approved for sepsis-associated acute respiratory distress syndrome, but its efficacy for other rapidly progressive interstitial pneumonias (RPIPs)